Journal of Hepatocellular Carcinoma
Volume 10, 2023 - Issue
Open access
179
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma
Jin Lei1 School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of ChinaView further author information
, Sibo Yang1 School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of ChinaView further author information
, Bowen Chen2 302 Clinical Medical School, Peking University, Beijing, People’s Republic of ChinaView further author information
, Linzhi Zhang3 Comprehensive Liver Cancer Center, the 5th Medical Center of the PLA General Hospital, Beijing, People’s Republic of ChinaView further author information
, Tao Yan3 Comprehensive Liver Cancer Center, the 5th Medical Center of the PLA General Hospital, Beijing, People’s Republic of ChinaView further author information
, Gangqi Yang1 School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of ChinaView further author information
, Yue Chen1 School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of ChinaView further author information
, Yinyin Li3 Comprehensive Liver Cancer Center, the 5th Medical Center of the PLA General Hospital, Beijing, People’s Republic of ChinaView further author information
, Yinying Lu1 School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of China;3 Comprehensive Liver Cancer Center, the 5th Medical Center of the PLA General Hospital, Beijing, People’s Republic of China;4 Center for Synthetic and Systems Biology, School of Life Sciences, Tsinghua, Beijing, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
& View further author information
Shi Zuo1 School of Clinical Medicine, Guizhou Medical University, Guiyang, People’s Republic of China;5 Department of Hepatobiliary Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of ChinaView further author information
show all
Pages 357-367
|
Received 12 Oct 2022, Accepted 16 Feb 2023, Published online: 02 Mar 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.